CEO North America > CEO Life > Health
Novo Nordisk's new weight loss drug, amycretin, is showing greater potential than Wegovy for weight loss, as its trial resulted...
A seven-year study of people with myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS, done by the National Institutes of Health found...
Smoking tobacco changes the immune system, putting people at greater risk of diseases and infection, and the effect can last...
Cancer rates are rising, with diagnoses expected to increase 55% globally between 2022 and 2045, going from about 19.9 million...
This year saw 21.3 million people sign up for health insurance on Affordable Care Act marketplaces, marking a 30.7% annual increase,...
On Monday, the Biden administration announced that the U.S. government will once again be offering free at-home Covid-19 testing kits...
The days of yellow and brown smoke transforming the likes of New York City and Washington, D.C. into a surreal...
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the way for...
Millions of people awoke this week to hazy skies and a dim red sun, its light filtered through smoke released...
The World Health Organization said Thursday that the global outbreak of mpox, which initially baffled experts when the smallpox-related disease spread to...
Editorials –
stuart.james@ceo-na.com
Advertising –
advertising@ceo-na.com
NEW YORK
110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800
HOUSTON
609 Main St.
Floor 25
Houston, TX
77002
USA
NEW YORK
110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800
HOUSTON
609 Main St.
Floor 25
Houston, TX
77002
USA
CEO North America © 2022 - Sitemap